A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening.

about

Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).

P2860

Q47246053-2D96FB98-71E8-4377-B885-F43DD70F1FA9

P2860

A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening.

Item

http://www.wikidata.org/entity/Q41063014

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A Novel Role for RARα Agonists ...... rom High Throughput Screening.

@en

type

Item

label

A Novel Role for RARα Agonists ...... rom High Throughput Screening.

@en

prefLabel

A Novel Role for RARα Agonists ...... rom High Throughput Screening.

@en

P1476

A Novel Role for RARα Agonists ...... rom High Throughput Screening.

@en

P2093

Danling Wang

http://www.w3.org/2001/XMLSchema#string

Dawna Caballero

http://www.w3.org/2001/XMLSchema#string

Elizabeth Chao

http://www.w3.org/2001/XMLSchema#string

Huafei Zou

http://www.w3.org/2001/XMLSchema#string

Hung Nguyen

http://www.w3.org/2001/XMLSchema#string

Jose Gonzalez

http://www.w3.org/2001/XMLSchema#string

Madhupriya Mahankali

http://www.w3.org/2001/XMLSchema#string

Mitch Hull

http://www.w3.org/2001/XMLSchema#string

Peter G Schultz

http://www.w3.org/2001/XMLSchema#string

Sang Jun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway

The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression

Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of l

All-trans-retinoic acid in acute promyelocytic leukemia

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

P2888

s41598-017-05163-w

P304

5824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-05163-W

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Weijun Shen

Abdallah Bitar

P577

2017-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090707238

http://www.w3.org/2001/XMLSchema#string

P698

28724938

http://www.w3.org/2001/XMLSchema#string

P932

5517646

http://www.w3.org/2001/XMLSchema#string

A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening.

about

P2860

P2860

A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932